![An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia - Al‐Samkari - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia - Al‐Samkari - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/3235a9bf-f499-46dd-a7c9-32a4375a5d09/bcp13717-fig-0001-m.jpg)
An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia - Al‐Samkari - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library
![Novartis issues voluntary nationwide recall of Promacta® 12.5 mg for oral suspension due to potential peanut contamination Novartis issues voluntary nationwide recall of Promacta® 12.5 mg for oral suspension due to potential peanut contamination](https://mma.prnewswire.com/media/885629/Novartis___Promacta.jpg)
Novartis issues voluntary nationwide recall of Promacta® 12.5 mg for oral suspension due to potential peanut contamination
![Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination | FDA Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination | FDA](https://www.fda.gov/files/styles/recall_image_small/public/Image%202_2.jpg?itok=NBaoEU5W)
Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination | FDA
![Novartis issues voluntary nationwide recall of Promacta® 12.5 mg for oral suspension due to potential peanut contamination Novartis issues voluntary nationwide recall of Promacta® 12.5 mg for oral suspension due to potential peanut contamination](https://mma.prnewswire.com/media/885630/Novartis_Promacta_2.jpg?p=facebook)
Novartis issues voluntary nationwide recall of Promacta® 12.5 mg for oral suspension due to potential peanut contamination
![These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA® (eltrombopag) tablets, for oral usePROMACTA® (eltrombopag) for oral suspensionInitial U.S. These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA® (eltrombopag) tablets, for oral usePROMACTA® (eltrombopag) for oral suspensionInitial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=promacta-spl-graphic-16.jpg&id=721800)
These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA® (eltrombopag) tablets, for oral usePROMACTA® (eltrombopag) for oral suspensionInitial U.S.
![Promacta® Oral Suspension Recalled for Possible Peanut Contamination | Asthma and Allergy Foundation of America Promacta® Oral Suspension Recalled for Possible Peanut Contamination | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/518388543130060320/primaryPicture/true/fodoid/518388543130149971/imageType/LARGE/inlineImage/true/medicine-recall-alert-Novatris-Promacta.png)